Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Receivables - Affiliates (2016 - 2023)

Fortress Biotech has reported Receivables - Affiliates over the past 9 years, most recently at $636000.0 for Q1 2023.

  • Quarterly results put Receivables - Affiliates at $636000.0 for Q1 2023, up 0.79% from a year ago — trailing twelve months through Mar 2023 was $636000.0 (up 0.79% YoY), and the annual figure for FY2022 was $138000.0, down 79.65%.
  • Receivables - Affiliates for Q1 2023 was $636000.0 at Fortress Biotech, up from $138000.0 in the prior quarter.
  • Over the last five years, Receivables - Affiliates for FBIO hit a ceiling of $2.1 million in Q1 2019 and a floor of $138000.0 in Q4 2022.
  • Median Receivables - Affiliates over the past 5 years was $849000.0 (2021), compared with a mean of $924058.8.
  • Peak annual rise in Receivables - Affiliates hit 200.24% in 2019, while the deepest fall reached 84.45% in 2019.
  • Fortress Biotech's Receivables - Affiliates stood at $865000.0 in 2019, then dropped by 13.99% to $744000.0 in 2020, then dropped by 8.87% to $678000.0 in 2021, then crashed by 79.65% to $138000.0 in 2022, then soared by 360.87% to $636000.0 in 2023.
  • The last three reported values for Receivables - Affiliates were $636000.0 (Q1 2023), $138000.0 (Q4 2022), and $153000.0 (Q3 2022) per Business Quant data.